Suchergebnisse - "Biological Factors"

PubPharm (677)

1

Synthetic Pyrethroid, Natural Product, and Entomopathogenic Fungal Acaricide Product Formulations for Sustained Early Season Suppression of Host-Seeking Ixodes scapularis (Acari : Ixodidae) and Amblyomma americanum Nymphs

enthalten in: Journal of medical entomology | 2021

von Schulze, T. | Jordan, R.

2

A Model-Based Approach to Quantify the Time-Course of Anti-Drug Antibodies for Therapeutic Proteins

enthalten in: Clinical pharmacology and therapeutics | 2019

von Ren, Y. | Li, L. | Kirshner, S. | +3

3

Refocusing IBD Patient Management : Personalized, Proactive, and Patient-Centered Care

enthalten in: The American journal of gastroenterology | 2018

von Siegel, C.

4

Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer

enthalten in: JAMA dermatology | 2016

von Scott, F. | Mamtani, R. | Brensinger, C. | +11

5

Risk of serious infection in biological treatment of patients with rheumatoid arthritis : a systematic review and meta-analysis

enthalten in: Lancet (London, England) | 2015

von Singh, J. | Cameron, C. | Noorbaloochi, S. | +8

CommentIn: Lancet. 2015 Jul 18;386(9990):224-5. - PMID 25975453

6

Risk of hospitalized infection among rheumatoid arthritis patients concurrently treated with a biologic agent and denosumab

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2015

von Curtis, J. | Xie, F. | Yun, H. | +3

7

Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease

enthalten in: Inflammatory bowel diseases | 2013

von Dulai, P. | Siegel, C. | Dubinsky, M.

8

Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US medicare program

enthalten in: Arthritis care & research | 2013

von Zhang, J. | Xie, F. | Delzell, E. | +6

CommentIn: Arthritis Care Res (Hoboken). 2014 Aug;66(8):1269. - PMID 24577787

9

Injectable tumor necrosis factor α inhibitors and outpatient antimicrobial use in children with rheumatic diseases : analyses of prescription claims from a pharmacy benefit manager database

enthalten in: Arthritis care & research | 2013

von Ringold, S. | Grant, S. | Girdish, C. | +2

10

Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R))

enthalten in: Biochemical pharmacology | 2008

von Robey, R. | Shukla, S. | Finley, E. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[68]